Detalles de la búsqueda
1.
Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a â¼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.
RNA Biol
; 12(1): 82-91, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25826415
2.
RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
Oncotarget
; 7(15): 20561-73, 2016 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26967392
3.
Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells.
J Drug Target
; 23(1): 59-66, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25185784
4.
Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
BMC Syst Biol
; 8: 82, 2014 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25000828
5.
VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.
Hematology
; 18(6): 334-40, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24129092
6.
miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML).
PLoS One
; 7(3): e32834, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22442671
7.
Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells.
Cell Signal
; 24(6): 1134-40, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22330069
Resultados
1 -
7
de 7
1
Próxima >
>>